Crossmark

Invited Commentary: Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination, by Levine et al.

Crossref DOI link: https://doi.org/10.1245/s10434-024-16716-5

Published Online: 2024-12-18

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alexander, H. Richard
License Information

Text and Data Mining valid from 2024-12-18

Version of Record valid from 2024-12-18
More Information

Article History

Received: 13 November 2024

Accepted: 1 December 2024

First Online: 18 December 2024

Disclosures

: H. Richard Alexander has no conflicts of interest to declare that may be relevant to the contents of this commentary.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below